96 related articles for article (PubMed ID: 20670603)
1. The biology of melanoma prognostic factors.
Spatz A; Stock N; Batist G; van Kempen LC
Discov Med; 2010 Jul; 10(50):87-93. PubMed ID: 20670603
[TBL] [Abstract][Full Text] [Related]
2. The biology behind prognostic factors of cutaneous melanoma.
Spatz A; Batist G; Eggermont AM
Curr Opin Oncol; 2010 May; 22(3):163-8. PubMed ID: 20177382
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma.
Clemente CG; Mihm MC; Bufalino R; Zurrida S; Collini P; Cascinelli N
Cancer; 1996 Apr; 77(7):1303-10. PubMed ID: 8608507
[TBL] [Abstract][Full Text] [Related]
4. Progress in melanoma histopathology and diagnosis.
Piris A; Mihm MC
Hematol Oncol Clin North Am; 2009 Jun; 23(3):467-80, viii. PubMed ID: 19464597
[TBL] [Abstract][Full Text] [Related]
5. Breslow thickness and clark level in melanoma: support for including level in pathology reports and in American Joint Committee on Cancer Staging.
Marghoob AA; Koenig K; Bittencourt FV; Kopf AW; Bart RS
Cancer; 2000 Feb; 88(3):589-95. PubMed ID: 10649252
[TBL] [Abstract][Full Text] [Related]
6. Reflecting on the 2001 American Joint Committee on Cancer Staging System for melanoma.
Retsas S; Mastrangelo MJ
Semin Oncol; 2007 Dec; 34(6):491-7. PubMed ID: 18083372
[TBL] [Abstract][Full Text] [Related]
7. Microstaging in cutaneous melanoma.
Ruiter DJ; Spatz A; van den Oord JJ; Cook MG;
J Pathol; 2001 Dec; 195(5):525-9. PubMed ID: 11745686
[TBL] [Abstract][Full Text] [Related]
8. New American Joint Commission on Cancer staging system for melanoma: prognostic impact and future directions.
Ross MI
Surg Oncol Clin N Am; 2006 Apr; 15(2):341-52. PubMed ID: 16632219
[TBL] [Abstract][Full Text] [Related]
9. The history and future of melanoma staging.
Thompson JF; Shaw HM; Hersey P; Scolyer RA
J Surg Oncol; 2004 Jul; 86(4):224-35. PubMed ID: 15221929
[TBL] [Abstract][Full Text] [Related]
10. Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.
Kruper LL; Spitz FR; Czerniecki BJ; Fraker DL; Blackwood-Chirchir A; Ming ME; Elder DE; Elenitsas R; Guerry D; Gimotty PA
Cancer; 2006 Nov; 107(10):2436-45. PubMed ID: 17058288
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors of thin cutaneous melanoma: an analysis of the central malignant melanoma registry of the german dermatological society.
Leiter U; Buettner PG; Eigentler TK; Garbe C
J Clin Oncol; 2004 Sep; 22(18):3660-7. PubMed ID: 15302905
[TBL] [Abstract][Full Text] [Related]
12. Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
Gimotty PA; Elder DE; Fraker DL; Botbyl J; Sellers K; Elenitsas R; Ming ME; Schuchter L; Spitz FR; Czerniecki BJ; Guerry D
J Clin Oncol; 2007 Mar; 25(9):1129-34. PubMed ID: 17369575
[TBL] [Abstract][Full Text] [Related]
13. The New American Joint Committee on Cancer staging system for cutaneous melanoma: a critical analysis based on data of the German Central Malignant Melanoma Registry.
Garbe C; Ellwanger U; Tronnier M; Brocker EB; Orfanos CE
Cancer; 2002 Apr; 94(8):2305-7. PubMed ID: 12001131
[No Abstract] [Full Text] [Related]
14. Biomarkers in melanoma: staging, prognosis and detection of early metastases.
Carlson JA; Slominski A; Linette GP; Mihm MC; Ross JS
Expert Rev Mol Diagn; 2003 May; 3(3):303-30. PubMed ID: 12779006
[TBL] [Abstract][Full Text] [Related]
15. A single-institution validation of the AJCC staging system for stage IV melanoma.
Neuman HB; Patel A; Ishill N; Hanlon C; Brady MS; Halpern AC; Houghton A; Coit DG
Ann Surg Oncol; 2008 Jul; 15(7):2034-41. PubMed ID: 18465172
[TBL] [Abstract][Full Text] [Related]
16. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
[TBL] [Abstract][Full Text] [Related]
17. A population-based validation of the American Joint Committee on Cancer melanoma staging system.
Gimotty PA; Botbyl J; Soong SJ; Guerry D
J Clin Oncol; 2005 Nov; 23(31):8065-75. PubMed ID: 16258105
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic factors in thin cutaneous malignant melanoma].
Massi D; Franchi A; Santucci M
Pathologica; 2002 Dec; 94(6):282-9. PubMed ID: 12540991
[TBL] [Abstract][Full Text] [Related]
19. Lack of relevant information for tumor staging in pathology reports of primary cutaneous melanoma.
Busam KJ
Am J Clin Pathol; 2001 May; 115(5):743-6. PubMed ID: 11345839
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of malignant melanoma.
Rigel DS; Rogers GS; Friedman RJ
Dermatol Clin; 1985 Apr; 3(2):309-14. PubMed ID: 3830493
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
